Home > Naltrexone for the management of opioid dependence.

National Institute for Health and Clinical Excellence. (2007) Naltrexone for the management of opioid dependence. London: NICE. NICE technology appraisal guidance 115.

External website: http://guidance.nice.org.uk/TA115

Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.

It should only be given to people who have been told about the problems associated with treatment, and with proper supervision. Treatment with naltrexone should be given as part of a support programme to help the person manage their opioid dependence.

Healthcare professionals should regularly review how well naltrexone is working to help people stay off opioids. If there is evidence that the person has been using the drugs again then healthcare professionals should consider stopping naltrexone treatment.

Item Type
Publication Type
International, Guideline, Report, Web Resource
Drug Type
Intervention Type
Drug therapy, Treatment method
Identification #
NICE technology appraisal guidance 115
Corporate Creators
National Institute for Health and Clinical Excellence
Place of Publication
Accession Number
HRB (Electronic Only)
Related (external) link

Repository Staff Only: item control page